Chapter 15: disease gene prioritization.

Disease-causing aberrations in the normal function of a gene define that gene as a disease gene. Proving a causal link between a gene and a disease experimentally is expensive and time-consuming. Comprehensive prioritization of candidate genes prior to experimental testing drastically reduces the as...

Full description

Bibliographic Details
Main Author: Yana Bromberg
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-04-01
Series:PLoS Computational Biology
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23633938/pdf/?tool=EBI
id doaj-96c3201af4fe4d26a8d4aeeed96cc102
record_format Article
spelling doaj-96c3201af4fe4d26a8d4aeeed96cc1022021-04-21T15:25:24ZengPublic Library of Science (PLoS)PLoS Computational Biology1553-734X1553-73582013-04-0194e100290210.1371/journal.pcbi.1002902Chapter 15: disease gene prioritization.Yana BrombergDisease-causing aberrations in the normal function of a gene define that gene as a disease gene. Proving a causal link between a gene and a disease experimentally is expensive and time-consuming. Comprehensive prioritization of candidate genes prior to experimental testing drastically reduces the associated costs. Computational gene prioritization is based on various pieces of correlative evidence that associate each gene with the given disease and suggest possible causal links. A fair amount of this evidence comes from high-throughput experimentation. Thus, well-developed methods are necessary to reliably deal with the quantity of information at hand. Existing gene prioritization techniques already significantly improve the outcomes of targeted experimental studies. Faster and more reliable techniques that account for novel data types are necessary for the development of new diagnostics, treatments, and cure for many diseases.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23633938/pdf/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author Yana Bromberg
spellingShingle Yana Bromberg
Chapter 15: disease gene prioritization.
PLoS Computational Biology
author_facet Yana Bromberg
author_sort Yana Bromberg
title Chapter 15: disease gene prioritization.
title_short Chapter 15: disease gene prioritization.
title_full Chapter 15: disease gene prioritization.
title_fullStr Chapter 15: disease gene prioritization.
title_full_unstemmed Chapter 15: disease gene prioritization.
title_sort chapter 15: disease gene prioritization.
publisher Public Library of Science (PLoS)
series PLoS Computational Biology
issn 1553-734X
1553-7358
publishDate 2013-04-01
description Disease-causing aberrations in the normal function of a gene define that gene as a disease gene. Proving a causal link between a gene and a disease experimentally is expensive and time-consuming. Comprehensive prioritization of candidate genes prior to experimental testing drastically reduces the associated costs. Computational gene prioritization is based on various pieces of correlative evidence that associate each gene with the given disease and suggest possible causal links. A fair amount of this evidence comes from high-throughput experimentation. Thus, well-developed methods are necessary to reliably deal with the quantity of information at hand. Existing gene prioritization techniques already significantly improve the outcomes of targeted experimental studies. Faster and more reliable techniques that account for novel data types are necessary for the development of new diagnostics, treatments, and cure for many diseases.
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23633938/pdf/?tool=EBI
work_keys_str_mv AT yanabromberg chapter15diseasegeneprioritization
_version_ 1714667417101139968